Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Themis and Merck announced the companies have entered into a definitive agreement under which Merck, through a subsidiary, will acquire privately-held Themis.
read more
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), today announced that the companies have entered into a definitive agreement under which Merck will acquire Idenix for $24.50 per ...
read more
Merck Serono, a division of Merck in Darmstadt, Germany, announced today a first employment initiative for its employees affected by the restructuring of its operations in Switzerland. Quintiles, the world's leading biopharmaceutical services company...
read more
Wednesday, August 19, 2015
Merck is recalling 276,000 bottles of a chemotherapy drug because the child-proof caps on the pill bottles may be cracked.
read more
Merck announced the opening of its first joint Process Scale-Up Lab in Bengaluru, India to provide end-to-end solutions from process development to scale-up manufacturing for pre-clinical, clinical and commercial supply.
read more
Friday, September 22, 2017
Merck has announced the opening of its first BioReliance End-to-End Biodevelopment Center in the Asia Pacific region.
read more
Tuesday, January 07, 2014
The German pharmaceutical, chemical and
life science company Merck KGaA, Darmstadt, Germany, broke ground today on a new
production facility for its Allergopharma unit in Reinbek near Hamburg. The new facility,
which is estimated to cost nearly € ...
read more
Wednesday, March 20, 2019
Merck KGaA, Darmstadt, Germany and Pfizer announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating avelumab in combination with chemotherapy.
read more
Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its biopharmaceutical business in the US and Canada as EMD Serono, has entered into a collaboration and licensing agreement with Domain Therapeutics, Strasbourg, ...
read more
Friday, February 28, 2020
Merck KGaA, Darmstadt, Germany and AMCM, Starnberg, Germany, announced a cooperation agreement on the 3D printing of tablets.
read more
Wednesday, September 21, 2022
Accumulus Synergy, a non-profit organization working to develop an information and data exchange platform aimed at transforming how life science innovators and health authorities worldwide interact, announced that Merck, known as MSD outside the ...
read more
Merck announced an investment of €150 million in its manufacturing site at Aubonne, Switzerland, to expand manufacturing capacity for its biotech medicines.
read more
Wednesday, September 21, 2022
Merck will initiate a new Phase 3 clinical program with once-daily islatravir for the treatment of people with HIV-1 infection.
read more
Wednesday, November 18, 2015
Merck KGaA, Darmstadt, Germany, has announced the completion of its $17 billion acquisition of Sigma-Aldrich.
read more
Merck announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of ArQule at a purchase price of $20.00 per share.
read more